Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-12-28 | 2021-01-26 | 130719 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-12-28 | 2021-02-11 | 130722 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-09 | 131166 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2021-01-08 | 2021-01-20 | 131176 |
| APO-RAMIPRIL | 15MG | CAPSULE | Resolved | 2021-01-29 | 2021-03-24 | 132747 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2021-02-05 | 2021-02-09 | 133388 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-02-12 | 2021-03-09 | 133997 |
| APO-RAMIPRIL | 15MG | CAPSULE | Resolved | 2021-02-12 | 2021-03-24 | 134000 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-04-09 | 2021-05-03 | 137272 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2021-05-07 | 2021-06-07 | 138971 |
| APO-RANITIDINE | 15MG | SOLUTION | Actual shortage | 2019-09-18 | 2019-09-18 | 94180 |
| APO-RANITIDINE | 15MG | SOLUTION | Resolved | 2019-02-13 | 2019-04-05 | 75626 |
| APO-RANITIDINE | 15MG | SOLUTION | Resolved | 2019-05-22 | 2019-05-31 | 84541 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-03-12 | 2017-04-21 | 686 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-03-17 | 2017-07-26 | 3180 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-05-04 | 2017-07-26 | 8886 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-05-04 | 2017-07-31 | 8938 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-11-21 | 2018-09-29 | 29983 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Actual shortage | 2019-09-18 | 2019-09-18 | 94174 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-05-24 | 2017-07-26 | 11044 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |